| CAS Number | 905298-84-2 |
| Catalog Number | AG01EQF4(AGN-PC-3H479H) |
| Chemical Name | LIMK1 inhibitor BMS-4 |
| IUPAC Name | 1-ethyl-3-[5-[6-(4-methoxy-2,6-dimethylphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]urea |
| InChI | InChI=1S/C23H23N7O2S/c1-5-25-22(31)30-23-27-12-19(33-23)16-10-17(20-13(2)8-15(32-4)9-14(20)3)29-21(28-16)18-11-24-6-7-26-18/h6-12H,5H2,1-4H3,(H2,25,27,30,31) |
| InChI Key | WUCYRTXFXRZKSV-UHFFFAOYSA-N |
| MDL Number | MFCD24387531 |
| Molecular Formula | C23H23N7O2S |
| Molecular Weight | 461.5394 |
| SMILES | O=C(NCC)NC1SC(C2=CC(C3C(C)=CC(OC)=CC=3C)=NC(C3C=NC=CN=3)=N2)=CN=1 |
| Synonyms | CHEMBL2070615,
LIMK1 inhibitor BMS 4,
BMS 4,
GTPL8117,
SCHEMBL5999941,
BDBM50390791,
ZINC84707544,
compound 31 [PMID: 22902653],
NCGC00372509-03,
905298-84-2,
1-ethyl-3-(5-(6-(4-methoxy-2,6-dimethylphenyl)-2-(pyrazin-2-yl)pyrimidin-4-yl)thiazol-2-yl)urea,
COMPOUND 31,
D0FC4Y,
1-Ethyl-3-{5-[6-(4-methoxy-2,6-dimethylphenyl)-2-(2-pyraziny,
|
| Complexity | 632 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 461.163g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 33 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 461.544g/mol |
| Monoisotopic Mass | 461.163g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 143A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.6 |
GHS Hazard and Precautionary Statements
Certificate of Analysis
Lot Number